PubMed:26684240 / 91-285
Annnotations
LitCoin-entities
{"project":"LitCoin-entities","denotations":[{"id":"10974","span":{"begin":20,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"10975","span":{"begin":66,"end":74},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"db_id","subj":"10974","obj":"MESH:C535650"},{"id":"A5","pred":"db_id","subj":"10975","obj":"MESH:C535650"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin-sentences
{"project":"LitCoin-sentences","denotations":[{"id":"T2","span":{"begin":0,"end":194},"obj":"Sentence"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin-GeneOrGeneProduct-v0
{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T4","span":{"begin":58,"end":64},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":70,"end":74},"obj":"GeneOrGeneProduct"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin-Disease-MeSH
{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T2","span":{"begin":20,"end":64},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"originalLabel","subj":"T2","obj":"C535650"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin_Mondo_095
{"project":"LitCoin_Mondo_095","denotations":[{"id":"T2","span":{"begin":20,"end":64},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0000386"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin-MeSH-Disease-2
{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T2","span":{"begin":20,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":66,"end":74},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T2","obj":"C535650"},{"id":"A3","pred":"ID:","subj":"T3","obj":"DISEASE"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin-MONDO_bioort2019
{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T2","span":{"begin":20,"end":64},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":66,"end":74},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"#label","subj":"T2","obj":"C535650"},{"id":"A3","pred":"#label","subj":"T3","obj":"DISEASE"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}
LitCoin-training-merged
{"project":"LitCoin-training-merged","denotations":[{"id":"T82078","span":{"begin":66,"end":74},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T32171","span":{"begin":20,"end":64},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A79707","pred":"#label","subj":"T82078","obj":"DISEASE"},{"id":"A56438","pred":"#label","subj":"T32171","obj":"C535650"}],"text":"Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied."}